Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.06% | -24.18% | -32.86% | -39.47% | -16.73% |
| Total Depreciation and Amortization | -6.53% | -10.54% | -8.63% | -4.90% | -10.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.70% | 80.13% | 81.11% | 94.97% | 6.16% |
| Change in Net Operating Assets | 265.39% | -41.89% | 17.51% | 106.22% | -146.31% |
| Cash from Operations | 14.54% | -31.89% | -28.81% | 4.49% | -37.76% |
| Capital Expenditure | 41.14% | 86.80% | 92.57% | -112.50% | 5.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.02% | -529.85% | -1.72% | 216.32% | 133.40% |
| Cash from Investing | 0.43% | -545.13% | 0.69% | 217.29% | 132.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 409.58% | 509.36% | 55,946.99% | -62.06% | -99.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 409.58% | 509.36% | 84,151.81% | -62.06% | -99.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.30% | -1,181.36% | 1,721.42% | 144.13% | 143.29% |